BiotechTube
BioTuring

BioTuring

San Diego, United States· Est.
bioturing.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11.7M

Overview

BioTuring is a private, revenue-generating bioinformatics software company offering an integrated ecosystem of AI-powered platforms for single-cell and spatial biology data analysis. Its core products include SpatialX for spatial transcriptomics, BBrowserX for single-cell RNA-seq, Talk2Data as a curated dataset database, and SmartBulk for bulk RNA-seq. The company serves a global customer base of over 10,000 scientists across academia and industry, positioning itself as a key enabler in the rapidly growing fields of spatial and single-cell omics.

AI / Machine LearningGenetics & Genomics

Technology Platform

Integrated software ecosystem powered by deep learning for analyzing single-cell and spatial multi-omics data. Includes platforms for spatial transcriptomics (SpatialX), single-cell RNA-seq (BBrowserX), a curated public dataset database (Talk2Data), and bulk RNA-seq analysis (SmartBulk).

Funding History

3
Total raised:$11.7M
Series A$8.7M
Seed$1.8M
Seed$1.2M

Opportunities

The explosive growth of spatial biology and single-cell multi-omics creates a massive, expanding market for user-friendly analysis software.
BioTuring's non-coding, integrated platform is well-positioned to capture researchers transitioning from bulk to spatial analysis and those in pharma seeking to accelerate drug discovery.
Further integration with AI and expansion of its curated database could create significant competitive moats.

Risk Factors

Faces intense competition from both large commercial instrument vendors with bundled software and popular open-source tools.
Success is highly dependent on rapidly adapting to new data formats from evolving spatial technologies, requiring constant R&D investment.
Market adoption among cost-conscious academic labs can be challenging when competing against free alternatives.

Competitive Landscape

BioTuring competes in a crowded field including instrument-linked software (10x Genomics Loupe, Akoya Phenoptics, Vizgen MERSCOPE), large bioinformatics suites (Qiagen CLC, Partek Flow, Thermo Fisher), and dominant open-source frameworks (Seurat, Scanpy). Its key differentiators are a Windows-native environment, a non-coding interface, and an integrated ecosystem spanning single-cell to spatial analysis.

More companies in AI / Machine Learning →More companies in United States →